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As BI products and services increasing, the cost for collecting data and storing data is reclined. Enterprises could get the 
data source from customer transactions, website logs and product reviews. BI technology is used in many fields, such as in 
manufacturing for order shipment and customer support, in financial services for claims analysis and fraud detection, in 
transportation for fleet management, in retail for user profiling to target grocery coupons during checkout, in utilities for 
power usage analysis, and health care for outcomes analysis. 
The profession of pharmacy will be more reliant upon the information that can be extracted from data analytics and BI 
tools.  There is a great opportunity in pharmacy to develop an analytical platform to suit both business needs in retail and the 




Business Intelligence, Analytical Platform, interventions, retail pharmacy 
INTRODUCTION 
In the past decade, data analytics (DA) and business intelligence (BI) platforms have become increasingly adopted by 
large businesses as a tool to identify competitive advantages.  BI comprises an integrated array of IT capabilities that allow 
users to transform complex data into informed actions (Ferranti et al., 2010).  The analytic platform has emerged as a 
powerful format to help businesses analyze large volumes of unstructured data across multiple business units and databases.  
The speed, affordability, and flexibility of the analytic platform have made it a widely adopted tool for generating business 
intelligence (Adrian et al., 2010).  Ultimately, the goal for BI is to generate timely information and support for assisting 
organizations in making better-informed decisions more quickly to navigate in the changing business environment.   
As BI products and services increasing, the cost for collecting data and storing data is reclined. Enterprises could get the 
data source from customer transactions, website logs and product reviews. BI technology is used in many fields, such as in 
manufacturing for order shipment and customer support, in financial services for claims analysis and fraud detection, in 
transportation for fleet management, in retail for user profiling to target grocery coupons during checkout, in utilities for 
power usage analysis, and health care for outcomes analysis (Chaudhuri et al. 2011).  
The need for the healthcare industry to modernize has been widely recognized.  In 2001, the Institute of Medicine (IOM) 
Call to Action identified several areas in need for adopting the use of IT technology.  A few of the specific needs listed 
addressed the benefits of adopting electronic health records, utilizing computerized physician order entry, and creating 
integrated databases.  In 2009, the American Recovery and Reinvestment Act and the US Department of Health and Human 
Services specifically addressed the need for improving the IT infrastructure in healthcare, seeking to strengthen the use of 
databases to improve clinical services and to support the adoption of evidence-based medicine by healthcare providers 
(Ferranti et al., 2010).   Overall, the goal of the combined efforts to modernization of healthcare is to improve efficiency, 
safety, and outcomes. 
   Healthcare delivery in the United States is challenged by demands of access, safety, quality, and cost (ACCP).  
Healthcare can be delivered by many providers and is increasingly being delivered by pharmacists.  Pharmacists play an 
integral role in providing healthcare services.  Pharmacists provide patient education about the appropriate medication use, 
monitoring of patient safety through drug utilization review, and improving medication adherence.  The collective efforts 
reduce healthcare costs and improve patient outcomes (ASHP). The profession of pharmacy will be more reliant upon the 
information that can be extracted from data analytics and BI tools.  There is a great opportunity in pharmacy to develop an 
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BI uses analytical software to extract information from large sets of data from a variety of sources.  The data to be 
analyzed can be from multiple databases (e.g. in-house, data warehouses, data marts, etc.) and from different data types (e.g. 
structured, unstructured, videos, text, etc.). The data for BI tasks often comes from different sources—typically from multiple 
operational databases across departments within the organization, as well as external vendors. Thus the problems of 
integrating, cleansing, and standardizing data in preparation for BI tasks can be rather challenging. Efficient data loading is 
imperative for BI. Moreover, BI tasks usually need to be performed incrementally as new data arrives, for example, last 
month’s sales data. This makes efficient and scalable data loading and refresh capability imperative for enterprise BI. These 
back-end technologies for preparing the data for BI are collectively referred to as Extract-Transform-Load (ETL) tools. 
Increasingly there is a need to support BI tasks in near real time, that is, make business decisions based on the operational 
data itself. 
BI could not only help the enterprises but also their customers. In retail pharmacy, BI technology is used to identify drug 
interactions and predict further. Today, pharmacies are recording more and more information, and that information (or data) 
is growing, consuming more and more storage space and becoming harder to manage. The reasons vary for the need to record 
such massive amounts of information. Sometimes the reason is adherence to compliance regulations, at other times it is the 
need to preserve translations, and in many cases it is simply part of a backup strategy. Those data storage costs time and 
money. Ohlhorst (2012) states the big challenge is how can business to find the value of the data and to explore data sources 
in more interesting and applicable ways to develop intelligence that can drive decisions, find relationships, solve problems, 




Analytic platforms have emerged to simultaneously address the need for data management and data storage from 
processing large volumes of data from a variety of sources to improve their business intelligence.  The analytic platform is a 
system design for addressing the needs for companies driven by information generated from data with the need for quick 
processing.  Analytic platforms contain two essential elements; a database management system paired with the analytic 
processing programs.  
The analytic platform features of speed, affordability, flexibility, and reliability make it a desirable tool for creating BI.  
The platforms leverage higher bandwidth connections and use modern container constructs in memory, which allows the 
coordination of multiple processes to operate efficiently in parallel (Adrian).   For example, IBM Netezza has an analytical 
platform with preconfigured hardware-software system that is able to perform complex analytical queries 10 to 100 times 
faster than traditional systems (Laudon).  The hardware required is inexpensive and can be integrated without having to 
disrupt daily operations (Adrian).  Simultaneously as data is generated, the analytic platform is able to update the information 
into the appropriate database(s).  As the strategy and scope of the business expands or shifts, the analytic software costs can 




Griffiths et al. (2012) argued that online social networks and professional networks have the potential to change patterns 
of health inequalities and access of health care, and lead to a reformulation of the role of health professionals. In particular, 
those who suffer from living with chronic illness and disability are disproportionately affected. Patients with chronic illness 
have greater reliance on the care directly provided through appointments with their physicians and consultations with retail 
pharmacists. Often health care consumers do not have sufficient knowledge of health care to adequately manage their chronic 
conditions, and it is not uncommon that customers do not know the normal range of their blood pressure or their blood 
pressure goals.  The availability of pharmacist to deliver consultations make this a widely service to fortify a patients 
resources for decision-making. Pharmacist provides suggestions to the patients/customers when they come to ask them. The 
consultations do not charge customers, making this free consultation costly to provide.  
In the healthcare industry, BI services are widely utilized for outcomes analysis (Chaudhuri et al. 2011).  BI could not 
only aid business operations but also patient care. In retail pharmacy, BI technology is used to identify drug interactions and 
predict further. Today, healthcare systems are recording more and more information, and that information (or data) is 
growing in the form of consuming more and more storage space and becoming harder to manage. The reasons vary for the 
need to record such massive amounts of information. Sometimes the reason is adherence to compliance regulations, at other 
times it is the need to preserve translations, and in many cases it is simply part of a backup strategy. Data storage costs time 
and money. Ohlhorst (2012) states the big challenge is for business to find the value in data and explore data sources in more 
interesting and applicable ways to develop intelligence that can drive decisions.  
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The improved adherence increases costs on drug but leverage the larger reduction in medical costs. In retail pharmacy, 
customer or patients are likely consult their health care consideration with pharmacist. This process happens many times per 
day and the questions are mostly related to chronic diseases. Pharmacist provides valuable suggestions, educates drug therapy 
to their customer or patients and motivates behavior changes. Adherence intervention could provide valuable suggestions to 
the patients and may change their behavior. However, this procedure cost pharmacist much time and the cost is high for the 
pharmacy per se. Patients need talk to the pharmacist less time and pharmacist could identify valuable interventions after 
several tries. There is little study for the costs of adherence interventions. We are focusing on how to reduce costs of 
adherence interventions and then patients and pharmacy get the benefits from it. Although medication adherence reduces the 
most of amount of expenditures, it still has costs itself. Patients or customers visit retail pharmacy and consult their problem 
with pharmacist. This procedure would generate extremely large data set that have grown beyond the ability of management 
and analyze them with traditional processing tools. If we can capture those data and store them in a database, those will bring 
to the retail pharmacy more valuable information. Using these data, we can 
analyze them using BI technology to identify the valuable interventions and 
provide the results to pharmacist and customers. Then, create a new platform 
utilizes those data and results with data from existing database.  
 
OBJECTIVES 
The goal from this research paper is to propose the adoption of using an 
integrated analytic platform as a way to improve the efficiency of providing 
pharmaceutical care and capturing valuable interventions in retail pharmacy.  
The results of this paper will: 
 Outline a procedure for a typical encounter  
 Identify the types of resources that could be accessed and made 
available during the encounter 
 Offer a theoretical framework for how the analytic platform will 
function 
 Describe the types of outcomes as a result from the encounter 
 
PROPOSED WORK 
In this proposal, our goal is to use BI and analytics to help patients and 
customers better manage their conditions when making decisions and to reduce 
to cost for both patients and pharmacy. This will require sophisticated data 
analysis techniques and to deliver new functionality, such as personalized 
offers and services to customers or patients. The analytic platform will be 
adopted for enhancing a customer-service platform driven by pharmacists.  
Secondarily, the platform will streamline and document the delivery of 
pharmaceutical care programs in conjunction with other healthcare-service 
related platforms. Lastly, the accumulation of data and sequencing will be able 
to generate healthcare BI for creating new programs to improve healthcare 
services.   
The proposed work does not fully address issues related to patient privacy 
(HIPAA), governance of healthcare databases, the additional risk shared 
between client, provider, and business, or the legal parameters within the scope 
of practice of pharmacy as defined by state boards of health.   
 
DATA COLLECTION  
 
The goal for data collection procedures is to collect only relevant 
information in a timely manner.  Expedient delivery of the service with the 
acceptance of the advice will be critical for the success of this platform.   Figure 1 illustrates the process for delivering the 
service. 
Once the customer presents, the pharmacist will use a personal assistant device with a touch screen (such as a tablet) to begin 
the process.  During the session, the pharmacist can enter the required data into the blank fields or the information can be 




Collect relevant health 
history and treatment history 
Utilization of resources  
Determine clinically 
appropriate intervention(s)  
Document intervention 
acceptance  
Characterize reason(s) for 
declined interventions  
Patient Follow-up  
Identify high value 
interventions 
Figure 1 Stepwise Process of Service 
Delivery Model 
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(e.g. product selection, safety, general health advice, screening, etc.).  The pharmacist will then identify the areas of concern 
for the customer in order to prioritize the most appropriate set of recommendations for the intervention.  Following the 
delivery of the service, the pharmacist will document whether the advice was accepted or declined with an attempt to 
characterize reasons for non-acceptance.  Any supporting operations required for complete service will be initiated at this 
point (email product, requested information, contact doctor, etc.). 
The delivery of healthcare services will relay data in real time by using a digital touch-screen personal assistant device as 
illustrated in figure 2.  The personal assistant device can retrieve essential information from the EHR through its application 
program interface (API).  As the service session occurs, a set of concerns by the patient will be generated.  The relevant 
demographic, medical, and prescription information can then be uploaded and paired with the concerns.  The set of possible 
solutions will then be filtered by screening for any of the alerts identified (Drug interactions, age considerations, health 
conditions, etc.) collected from the electronic health records database.  The final set of options will consider best practices 
(clinical), most utilized (non-clinical), out-of-pocket cost, and risk assessment.  The pharmacist will document the patient 
selection and attempt to characterize rationale for choice.  Once the session has reached its conclusion, the session will be 
uploaded back to the server.  Identification of valuable interventions will help assess demand for services and drive service 
design. 
 
IMPACT AND DISSEMINATION 
The ability of the analytic platform to retrieve information across multiple platforms quickly would allow the pharmacist 
to help the patient make informed decisions.  The device used by the pharmacist will have access to multiple drug 
information and healthcare resources.  In theory, this would assist the patient to achieve superior outcomes through the 
delivery healthcare intelligence.  The American Society of Health-Systems Pharmacists (ASHP) has identified five key areas 
for pharmacists to be able to enhance coordinated care and improve healthcare efficiency: 1) Medication management 2) 
Medication Reconciliation 3) Preventive Care services 4) Education and Behavior Counseling 5) Collaborative Care Models.  
Adopting the proposed analytic platform would achieve the goal for meeting these areas of opportunity.   
Adherence and Education 
The platform would address adherence by sending a push message from the platform based on claims. When delivering a 
consultation, the pharmacist could recommend that the prescription be refilled while offering advice as requested.  It is 
possible that the concern leading to the patient presentation for treatment could be due to non-adherence of a medication that 
was prescribed.  Reasons for non-adherence could be identified and uploaded through the analytic platform.  This would 
create an opportunity for the pharmacist to intervene and address issues related to education about the role and use of the 
medication, cost of medication, or resolving the medication reconciliation.   During the session, the intervention could be 
identified and uploaded to the services platform.  The pharmacist could use the cloud platform to access an action plan for 
addressing adherence and the database platform to monitor for improved outcomes. 
Preventing Avoidable Healthcare Costs 
Self-care is a will continue to be a strong presence in healthcare.  Consumers of healthcare services are frustrated by 
limited access to their primary care physicians, the cost of copays, long wait times and crowding of medical facilities and are 
demanding care that is more convenient and readily accessible (Kaissi).  When patients may not have affordable access to 
their doctor, they often rely upon the advice of a pharmacist.  The consistent delivery of proper problem identification paired 
with an appropriate over the counter approach has the chance to prevent unnecessary medical and prescription claims.  
Alternatively, the proper emphasis on prompt medical attention can also prevent an avalanche of additional medical expenses.  
Any consultation that assists the patient to self-manage their condition and prevents further medical costs could be considered 
a valuable intervention. 
Identification of Valuable Pharmacy Interventions 
      In retail settings, pharmacists are frequently consulted for advice on self-care.  Using the analytical platform, the 
pharmacist would be able to offer evidence based advice for the patient.  Many symptoms and conditions can be cost 
effectively managed with first line OTC treatment recommendations (acid reflux, constipation, seasonal allergies, etc.).  
When providing this information that proves to be beneficial to the patient, the decrease in total healthcare consumption can 
be seen as a favorable outcome for all stakeholders as a result of this intervention.  There are many opportunities in retail  
pharmacy to identify valuable interventions as a result of the consultation.  One frequent OTC consultations would be in 
assisting a patient with a concern related to constipation.  The following study highlights the opportunity pharmaceutical care. 
In February of 2014, Cai et. al. published a study in the Journal of Medical Economics evaluating direct healthcare costs 
attributed to chronic constipation.  The study evaluated medical and pharmacy claims from 14,854 commercially insured 
patients and compared the direct healthcare costs between patients without chronic constipation against the costs for patients 
with chronic constipation.  Adjusted incremental all-costs associated with chronic constipation were $3508 per patient per 
year.  The authors concluded this is a substantial burden attributable to chronic constipation.  
Tian & Schwartz                                                      The Use of Analytical Platform to Identify Valuable Interventions 




Figure 2. Data Processing Steps 
CONCLUSION 
As the modernization of the healthcare industry gains momentum, the valuable services that pharmacists provide will 
grow in demand.  The power of the analytical platform is in its ability to access multiple databases with the analytic 
processing program.  The importance of expediently gathering relevant information to personalize care is a valuable service 
for all stakeholders.  With the profession of pharmacy placed at the intersection between retail and healthcare, pharmacists 
have the enormous potential to use this technology to continue to improve an increasing number of patient outcomes.  The 
adoption of this analytic platform will give pharmacies the visibility in demonstrating the value of pharmacist-led 
interventions.     
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